startups digital health weight loss glp-1 research2guidance Startups, big players ramp up

This is exciting news

What Is Retatrutide (GLP-3)

Excretion Pathways Based on the peptide structure and pharmacokinetic characteristics: Primary elimination likely occurs through hepatic metabolism and biliary excretion Renal excretion of intact peptide appears minimal given the molecular size and protein binding Clearance rates remain consistent across multiple doses, indicating no accumulation beyond steady-state Terminal elimination phase extends several days after the last dose The favorable pharmacokinetic profile, characterized by predictable absorption, limited drug interactions, and steady-state maintenance with weekly dosing, supports the clinical development strategy and dose escalation regimens employed in phase 2 and phase 3 trials

A 10 mg vial contains enough retatrutide for multiple injections spread across several weeks

GLP-1 and the neurobiology of eating control: Recent advances

Once we determine which GLP-1 injection is the most suitable for your weight loss program, we will start the administration of injections according to a pre-determined schedule